Pharmaceutical formulation affects titanocene transferrin interactions.
about
Unusual Synergism of Transferrin and Citrate in the Regulation of Ti(IV) Speciation, Transport, and ToxicityOrganometallic Titanocene-Gold Compounds as Potential Chemotherapeutics in Renal Cancer. Study of their Protein Kinase Inhibitory Properties.A ubiquitous metal, difficult to track: towards an understanding of the regulation of titanium(iv) in humans.Radionuclides transform chemotherapeutics into phototherapeutics for precise treatment of disseminated cancer.
P2860
Pharmaceutical formulation affects titanocene transferrin interactions.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Pharmaceutical formulation affects titanocene transferrin interactions.
@ast
Pharmaceutical formulation affects titanocene transferrin interactions.
@en
type
label
Pharmaceutical formulation affects titanocene transferrin interactions.
@ast
Pharmaceutical formulation affects titanocene transferrin interactions.
@en
prefLabel
Pharmaceutical formulation affects titanocene transferrin interactions.
@ast
Pharmaceutical formulation affects titanocene transferrin interactions.
@en
P2093
P2860
P356
P1433
P1476
Pharmaceutical formulation affects titanocene transferrin interactions.
@en
P2093
Ann M Valentine
Katherine M Buettner
Robert C Snoeberger
Victor S Batista
P2860
P304
P356
10.1039/C1DT10805K
P407
P577
2011-08-16T00:00:00Z